Skip to main content

Advertisement

SpringerLink
Log in

Expression of estrogen receptor β wt isoform (ERβ1) and ERβΔ5 splice variant mRNAs in sporadic breast cancer

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

In addition to Estrogen Receptor α (ERα) and Progesterone Receptor (PR), the Second Estrogen Receptor (ERβ) appears to play an important role not only in estrogen signaling, but also in the pathogenesis of cancer in estrogen dependent tissues. The existence of various isoforms and splice variants of both ERs additionally complicates elucidation of their physiological role and involvement in the process of carcinogenesis.

Methods

In this study, the expression of ERβ1 mRNA (wild type of β receptor) and splice variant ERβΔ5 mRNA (which codes for truncated protein) was measured by the quantitative RT-PCR (q RT-PCR) in the 60 samples of Breast Cancer (BC) and correlated with ERα and PR protein levels and with clinical and histopathological parameters.

Results

We found the inverse correlation of ERβΔ5 mRNA expression with the levels of PR and ERα proteins in the group of postmenopausal patients; we also report the lower expression of ERβ1 and ERβΔ5 mRNA in the larger tumors (>20 mm, T2, and T3) than in smaller ones (≤20 mm, T1). The decrease of ERβΔ5 mRNA expression in larger tumors is found to arise from ER-positive breast carcinomas. In addition, the portion of tumors with concomitant high expression of both transcripts matches up the known percentage of tumors resistant to endocrine therapy in patients with different ER/PR status.

Conclusions

As far as we know, this is the first study in which ERβΔ5 mRNA splice variant was quantified by real-time RT-PCR in the clinical samples of breast cancer tissue. Until now, the focus of clinical reports was the level of ERβ1, ERβ2, and ERβ5 isoforms. The higher expression of ERβΔ5 mRNA is associated with the indicators of low biological aggressiveness of tumor (low tumor size within ER-positive status in our study) suggesting that the uncontrolled local tumor growth may occur as the expression of ERβΔ5 mRNA decreases in estrogen-dependent breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Ariazi EA, Clark GM, Mertz JE (2002) Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res 62:6510–6518

    PubMed  CAS  Google Scholar 

  • Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P (2004) Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 11:537–551

    Article  PubMed  CAS  Google Scholar 

  • Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S (1998) Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol 54:105–112

    PubMed  CAS  Google Scholar 

  • Bollig A, Miksicek RJ (2000) An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription. Mol Endocrinol 14:634–649

    Article  PubMed  CAS  Google Scholar 

  • Brouillet JP, Dujardin MA, Chalbos D, Rey JM, Grenier J, Lamy PJ, Maudelonde T, Pujol P (2001) Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer. Int J Cancer 95:205–208

    Article  PubMed  CAS  Google Scholar 

  • Cheng G, Li Y, Omoto Y, Wang Y, Berg T, Nord M, Vihko P, Warner M, Piao YS, Gustafsson JA (2005) Differential regulation of estrogen receptor (ER)alpha and ERbeta in primate mammary gland. J Clin Endocrinol Metab 90:435–444

    Article  PubMed  CAS  Google Scholar 

  • Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159

    Article  PubMed  CAS  Google Scholar 

  • EORTC Breast Cancer Cooperative Group (1980) Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 9:1513–1515

    Google Scholar 

  • Esslimani-Sahla M, Simony-Lafontaine J, Kramar A, Lavaill R, Mollevi C, Warner M, Gustafsson JA, Rochefort H (2004) Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. Clin Cancer Res 10:5769–5776

    Article  PubMed  CAS  Google Scholar 

  • Fuqua SA, Schiff R, Parra I, Friedrichs WE, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Willson TM, Moore JT (1999) Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. Cancer Res 59:5425–5428

    PubMed  CAS  Google Scholar 

  • Girault I, Andrieu C, Tozlu S, Spyratos F, Bieche I, Lidereau R (2004) Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma. Cancer Lett 215:101–112

    Article  PubMed  CAS  Google Scholar 

  • Hall JM, McDonnell DP (1999) The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140:5566–5578

    Article  PubMed  CAS  Google Scholar 

  • Hirata S, Shoda T, Kato J, Hoshi K (2001) The multiple untranslated first exons system of the human estrogen receptor beta (ER beta) gene. J Steroid Biochem Mol Biol 78:33–40

    Article  PubMed  CAS  Google Scholar 

  • Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK, Fuqua SA (2004) Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 10:7490–7499

    Article  PubMed  CAS  Google Scholar 

  • Inoue S, Ogawa S, Horie K, Hoshino S, Goto W, Hosoi T, Tsutsumi O, Muramatsu M, Ouchi Y (2000) An estrogen receptor beta isoform that lacks exon 5 has dominant negative activity on both ERalpha and ERbeta. Biochem Biophys Res Commun 279:814–819

    Article  PubMed  CAS  Google Scholar 

  • Iwao K, Miyoshi Y, Egawa C, Ikeda N, Noguchi S (2000) Quantitative analysis of estrogen receptor-beta mRNA and its variants in human breast cancers. Int J Cancer 88:733–736

    Article  PubMed  CAS  Google Scholar 

  • Jensen EV, Cheng G, Palmieri C, Saji S, Makela S, Van Noorden S, Wahlstrom T, Warner M, Coombes RC, Gustafsson JA (2001) Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci USA 98:15197–15202

    Article  PubMed  CAS  Google Scholar 

  • Lazennec G (2006) Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett 231:151–157

    Article  PubMed  CAS  Google Scholar 

  • Lu B, Leygue E, Dotzlaw H, Murphy LJ, Murphy LC, Watson PH (1998) Estrogen receptor-beta mRNA variants in human and murine tissues. Mol Cell Endocrinol 138:199–203

    Article  PubMed  CAS  Google Scholar 

  • Miyoshi Y, Taguchi T, Gustafsson JA, Noguchi S (2001) Clinicopathological characteristics of estrogen receptor-beta-positive human breast cancers. Jpn J Cancer Res 92:1057–1061

    PubMed  CAS  Google Scholar 

  • Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM, Willson TM (1998) Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun 247:75–78

    Article  PubMed  CAS  Google Scholar 

  • Murphy LC, Peng B, Lewis A, Davie JR, Leygue E, Kemp A, Ung K, Vendetti M, Shiu R (2005) Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. J Mol Endocrinol 34:553–566

    Article  PubMed  CAS  Google Scholar 

  • Nilsen J, Mor G, Naftolin F (2000) Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. J Neurobiol 43:64–78

    Article  PubMed  CAS  Google Scholar 

  • Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y, Muramatsu M (1998) Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res 26:3505–3512

    Article  PubMed  CAS  Google Scholar 

  • Ohlsson H, Lykkesfeldt AE, Madsen MW, Briand P (1998) The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1. Cancer Res 58:4264–4268

    PubMed  CAS  Google Scholar 

  • Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277:1508–1510

    Article  PubMed  CAS  Google Scholar 

  • Park BW, Kim KS, Heo MK, Yang WI, Kim SI, Kim JH, Kim GE, Lee KS (2006) The changes of estrogen receptor-beta variants expression in breast carcinogenesis: decrease of estrogen receptor-beta2 expression is the key event in breast cancer development. J Surg Oncol 93:504–510

    Article  PubMed  CAS  Google Scholar 

  • Peng B, Lu B, Leygue E, Murphy LC (2003) Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol 30:13–29

    Article  PubMed  CAS  Google Scholar 

  • Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45

    Article  PubMed  CAS  Google Scholar 

  • Poola I, Abraham J, Baldwin K (2002) Identification of ten exon deleted ERbeta mRNAs in human ovary, breast, uterus and bone tissues: alternate splicing pattern of estrogen receptor beta mRNA is distinct from that of estrogen receptor alpha. FEBS Lett 516:133–138

    Article  PubMed  CAS  Google Scholar 

  • Poola I, Abraham J, Liu A (2002) Estrogen receptor beta splice variant mRNAs are differentially altered during breast carcinogenesis. J Steroid Biochem Mol Biol 82:169–179

    Article  PubMed  CAS  Google Scholar 

  • Poola I, Fuqua SA, De Witty RL, Abraham J, Marshallack JJ, Liu A (2005) Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbeta1 and ERbeta5: potential molecular targets for chemoprevention. Clin Cancer Res 11:7579–7585

    Article  PubMed  CAS  Google Scholar 

  • Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H (2001) Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537–2541

    PubMed  CAS  Google Scholar 

  • Saji S, Omoto Y, Shimizu C, Warner M, Hayashi Y, Horiguchi S, Watanabe T, Hayashi S, Gustafsson JA, Toi M (2002) Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor. Cancer Res 62:4849–4853

    PubMed  CAS  Google Scholar 

  • Shaw JA, Udokang K, Mosquera JM, Chauhan H, Jones JL, Walker RA (2002) Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J Pathol 198:450–457

    Article  PubMed  CAS  Google Scholar 

  • Shoda T, Hirata S, Kato J, Hoshi K (2002) Cloning of the novel isoform of the estrogen receptor beta cDNA (ERbeta isoform M cDNA) from the human testicular cDNA library. J Steroid Biochem Mol Biol 82:201–208

    Article  PubMed  CAS  Google Scholar 

  • Speirs V (2002) Oestrogen receptor beta in breast cancer: good, bad or still too early to tell? J Pathol 197:143–147

    Article  PubMed  CAS  Google Scholar 

  • Speirs V, Adams IP, Walton DS, Atkin SL (2000) Identification of wild-type and exon 5 deletion variants of estrogen receptor beta in normal human mammary gland. J Clin Endocrinol Metab 85:1601–1605

    Article  PubMed  CAS  Google Scholar 

  • Speirs V, Malone C, Walton DS, Kerin MJ, Atkin SL (1999) Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res 59:5421–5424

    PubMed  CAS  Google Scholar 

  • Tong D, Schuster E, Seifert M, Czerwenka K, Leodolte S, Zeillinger R (2002) Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines. Breast Cancer Res Treat 71:249–255

    Article  PubMed  CAS  Google Scholar 

  • User Bulletin #2 (2001) Comparative CT method: Applied Biosystems. http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf#search=%22user%20bulletin%202%20abi%22. Cited 3 Oct 2006

  • Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lupu R (1998) Expression of estrogen receptor beta messenger RNA variant in breast cancer. Cancer Res 58:210–214

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Serbian Ministry of Science and Environmental Protection (Grants 143010 and 145018).

Author information

Authors and Affiliations

  1. Department for Radiobiology and Molecular Genetics—RMG 080, Vinča Institute of Nuclear Sciences, Mike Petrovića Alasa 12-14, Vinča, PO Box 522, 11000, Belgrade, Serbia

    Vesna Mandušić & Bogomir Dimitrijević

  2. Institute for Oncology and Radiology of Serbia, Belgrade, Serbia

    Dragica Nikolić-Vukosavljević, Ksenija Kanjer & Zora Neškovic-Konstantinović

  3. Institute for Biological Research Siniša Stanković, Belgrade, Serbia

    Nikola Tanić

  4. Faculty of Medicine, University of Belgrade, Belgrade, Serbia

    Dušica Čeleketić

Authors
  1. Vesna Mandušić
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dragica Nikolić-Vukosavljević
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nikola Tanić
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ksenija Kanjer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zora Neškovic-Konstantinović
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dušica Čeleketić
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bogomir Dimitrijević
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vesna Mandušić.

Additional information

Vesna Mandušić and Dragica Nikolić-Vukosavljević equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mandušić, V., Nikolić-Vukosavljević, D., Tanić, N. et al. Expression of estrogen receptor β wt isoform (ERβ1) and ERβΔ5 splice variant mRNAs in sporadic breast cancer. J Cancer Res Clin Oncol 133, 571–579 (2007). https://doi.org/10.1007/s00432-007-0209-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-007-0209-x

Keywords

Search

Navigation